Business
Remdesivir study by World Health Organisation casts doubt, disputed by Gilead Sciences Inc – 7NEWS.com.au
The antiviral medication was one of the drugs used to treat US President Donald Trump after his COVID-19 diagnosis.
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug remdesivir does not help patients who have been admitted to hospital.
The American company told Reuters the data appeared inconsistent, the findings were premature and that other studies had validated the drugs benefits.
In a blow to one of the few drugs being used to treat people with COVID-19, the WHO said on Thursday its Solidarity trial had concluded that remdesivir a…
-
Noosa News16 hours agoFive suspected rat poison cases detected in South East Queensland
-
General14 hours agoMollie O’Callaghan crushes 200m short course world record as post-Titmus era begins
-
Noosa News16 hours agoHorror weekend of motorbike crashes as four riders killed on Aussie roads within hours
-
Noosa News10 hours agoTensions erupt on Melbourne streets as opposing immigration rallies held across Australian capitals